Metabolic Alkalosis and Mixed Acid-Base Disorders

Introduction

What is Metabolic Alkalosis?

• Metabolic alkalosis is a primary metabolic disturbance in which plasma bicarbonate levels are increased and is usually associated with an arterial pH greater than 7.45.¹
  • Hospitalized and perioperative patients are often found to have metabolic alkalosis, which coincides with changes in volume status, electrolyte balance, or mineralocorticoid activity.^2,3
  • Physiological states that involve gastrointestinal hydrogen ion loss from vomiting or nasogastric suction, increased diuretic therapy, and post-hypercapnic states tend to exacerbate metabolic alkalosis.^1,2
• Mixed acid-base disturbances are common in critically ill patients due to the presence of multiple pathophysiologic processes that often coexist.²

Physiologic Compensation

• The expected physiologic response to metabolic alkalosis is hypoventilation, which increases arterial carbon dioxide tension (PaCO₂).²
  • Normalization of pH is rarely achieved by ventilatory responses because respiratory compensation is limited by the need to maintain adequate oxygenation.²

Clinical Importance

• Although mild alkalemia may produce minimal symptoms, severe metabolic alkalosis can impair tissue oxygen delivery and alter cardiovascular and neurological function.¹
• Treatment aims to correct the specific factors responsible for the generation and maintenance of alkalosis, making accurate identification of the underlying mechanism crucial.¹

Pathophysiology

• Metabolic alkalosis results from a net increase in extracellular bicarbonate concentration. Under normal conditions, the kidneys rapidly excrete excess bicarbonate; however, alkalosis may persist when renal bicarbonate elimination is impaired.¹

• Coordinated transport processes in the proximal tubule and collecting duct regulate renal bicarbonate balance
  • In the proximal tubule, coupled sodium and bicarbonate reabsorption is partly mediated by the sodium-hydrogen exchanger, thereby influencing distal bicarbonate delivery.²
  • In the distal nephron, pendrin-mediated bicarbonate secretion occurs in exchange for chloride reabsorption, linking distal bicarbonate handling directly to chloride availability.²
  • Relative chloride depletion increases the strong ion difference and promotes metabolic alkalosis.²

• These renal transport processes are further modulated by physiological states that limit bicarbonate delivery or secretion:¹
  • Hypovolemia or reduced effective arterial blood volume
  • Hypokalemia
  • Chloride depletion
  • Reduced glomerular filtration rate
  • Excess mineralocorticoid activity

Evaluation

• Metabolic alkalosis is defined by an arterial pH greater than 7.45 with a serum bicarbonate concentration above the normal reference range (more than 26 mmol/L).^3,4
  • Assessment of PaCO₂ determines whether respiratory compensation is adequate; values outside the expected compensatory range suggest a mixed acid-base disorder.^3,4
• The initial evaluation should assess the clinical context, volume status, and laboratory findings.³
  • This includes extracellular fluid volume, history of vomiting, nasogastric suctioning, diuretic use, alkali ingestion, and serum electrolytes, magnesium, and renal function.³
• Urine chloride concentration is used to classify metabolic alkalosis by reflecting renal chloride handling and indirectly bicarbonate excretion:^3,4
  • Chloride-responsive metabolic alkalosis is characterized by urine chloride less than 20 mmol/L and contraction of extracellular fluid volume.^3,4
  • Chloride-resistant metabolic alkalosis is characterized by urine chloride greater than 20 mmol/L and is associated with conditions such as mineralocorticoid excess or persistent renal chloride loss.^3,4

Mixed Disorders

• Metabolic alkalosis frequently occurs as part of a mixed acid–base disorder and should be interpreted in the context of concurrent respiratory or metabolic abnormalities.²
• Mixed disorders should be suspected when laboratory findings are internally inconsistent.⁵
  • Mixed disorders are identified when abnormalities in pH, PaCO₂ and bicarbonate cannot be reconciled by a single primary acid-base disturbance.⁵
• Evaluation of PaCO₂ relative to bicarbonate elevation distinguishes appropriate compensation from mixed acid-base disorders.⁵
  • The expected PaCO₂ can be approximated as:

• In metabolic alkalosis, PaCO₂ increases due to compensatory hypoventilation.⁵
  • Loss of coordinated, parallel directional changes between PaCO₂ and bicarbonate reflects the presence of more than one active acid-base disturbance.⁵

• Clinical context is essential when interpreting mixed acid-base disorders.⁵
  • Mixed disorders are common in hospitalized and critically ill patients, where multiple pathophysiologic mechanisms often coexist.⁵

Perioperative Considerations

• In perioperative and critical care settings, metabolic alkalosis commonly arises from gastric losses, diuretic therapy, or post-hypercapnic states.²
  • Post-hypercapnic metabolic alkalosis should be considered in patients with chronic hypercapnia who undergo rapid correction of PaCO₂.²
• Acid-base disturbances such as metabolic alkalosis affect the potency and duration of anesthetic drugs, such as neuromuscular blocking agents.⁶
  • Anesthetic choice and dosing must account for altered drug interactions in the context of metabolic alkalosis.⁶
  • Non-depolarizing agents tend to be less potent in metabolic alkalosis because shifts in electrolytes and pH affect their interactions at the neuromuscular junction.⁶
• Alkalosis may alter respiratory compensation during controlled ventilation.⁶
  • Mechanical ventilation strategies should avoid exacerbating alkalemia through excessive hypocapnia while maintaining adequate gas exchange.⁶
• Electrolyte imbalances associated with metabolic alkalosis have perioperative implications.⁶
  • Hypokalemia can diminish neuromuscular blockade and increase arrhythmia risk, requiring correction prior to anesthesia.⁶
• Monitoring and drug selection should be individualized based on acid-base status.⁶
  • Agents with pH-dependent metabolism may behave differently in alkalotic states.⁶

Management

• Management of metabolic alkalosis targets the underlying cause and physiologic determinants. Treatment is directed at correcting the factors that contribute to bicarbonate generation.³
• Volume and chloride repletion correct chloride-responsive metabolic alkalosis.³
  • Isotonic saline (0.9% NaCl) restores chloride and volume in patients with metabolic alkalosis associated with extracellular fluid volume depletion.³
  • While chloride repletion promotes renal bicarbonate excretion, it is important to address ongoing chloride losses, such as those from vomiting.³
• Potassium and magnesium repletion are integral to correcting metabolic alkalosis, as hypokalemia promotes bicarbonate retention and hypomagnesemia may exacerbate potassium loss, necessitating replacement as indicated.³
• Medications that contribute to alkalosis should be identified and adjusted.³
  • Use of diuretics or other agents that promote volume contraction and electrolyte loss should be reconsidered when clinically feasible.³
• Persistent metabolic alkalosis may require medications to increase bicarbonate excretion.³
  • Acetazolamide, a carbonic anhydrase inhibitor, can be used to increase urinary bicarbonate excretion when alkalosis persists despite volume/electrolyte correction.³
• Renal replacement therapy, including dialysis, may be required in critically ill patients with severe metabolic alkalosis when conventional medical therapy is ineffective.³